Safety and Efficacy of Tenalisib (RP6530) in Combination With Romidepsin in Patients With Relapsed/Refractory T-cell Lymphoma
Condition: T Cell Lymphoma Intervention: Drug: Tenalisib Sponsor: Rhizen Pharmaceuticals SA Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials